IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.753
EU - Europa 2.569
AS - Asia 2.333
SA - Sud America 383
Continente sconosciuto - Info sul continente non disponibili 207
AF - Africa 66
OC - Oceania 4
Totale 9.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.649
SG - Singapore 1.095
IE - Irlanda 434
IT - Italia 432
CN - Cina 366
UA - Ucraina 318
RU - Federazione Russa 310
HK - Hong Kong 297
BR - Brasile 289
SE - Svezia 288
VN - Vietnam 215
DE - Germania 185
FI - Finlandia 182
FR - Francia 155
GB - Regno Unito 99
KR - Corea 74
IN - India 59
CA - Canada 51
BD - Bangladesh 37
AR - Argentina 35
TR - Turchia 27
IQ - Iraq 25
NL - Olanda 24
PL - Polonia 24
MX - Messico 22
ZA - Sudafrica 21
BE - Belgio 18
UZ - Uzbekistan 17
AT - Austria 16
CO - Colombia 16
ID - Indonesia 16
PK - Pakistan 15
ES - Italia 14
RO - Romania 14
SA - Arabia Saudita 14
CH - Svizzera 13
JP - Giappone 13
PH - Filippine 13
VE - Venezuela 13
CZ - Repubblica Ceca 10
EC - Ecuador 9
GR - Grecia 9
CR - Costa Rica 8
JO - Giordania 8
LB - Libano 8
KE - Kenya 7
LT - Lituania 7
MY - Malesia 7
OM - Oman 7
TN - Tunisia 7
BO - Bolivia 6
EG - Egitto 6
MA - Marocco 6
PY - Paraguay 6
CL - Cile 4
DZ - Algeria 4
JM - Giamaica 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
HN - Honduras 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
KZ - Kazakistan 2
LC - Santa Lucia 2
LV - Lettonia 2
ML - Mali 2
MU - Mauritius 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TW - Taiwan 2
UG - Uganda 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
KI - Kiribati 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
Totale 9.100
Salva come PNG Salva come JPEG
Città #
Singapore 810
Chandler 443
Dublin 434
San Jose 305
Hong Kong 296
San Mateo 287
Ashburn 277
Boardman 156
Perugia 151
Jacksonville 150
Santa Clara 122
Council Bluffs 115
Moscow 108
Beijing 103
Medford 82
Princeton 82
Lauterbourg 81
Munich 74
Altamura 71
Ann Arbor 70
Seoul 69
Wilmington 65
Andover 63
Dong Ket 59
New York 58
Helsinki 55
Lawrence 55
Los Angeles 54
Ho Chi Minh City 51
The Dalles 50
Turku 37
Dallas 33
Piscataway 33
Hanoi 32
Des Moines 30
São Paulo 30
Frankfurt am Main 28
Saint Petersburg 24
Norwalk 21
Rome 21
Woodbridge 21
Orem 20
Brooklyn 19
Montreal 17
Redwood City 17
Houston 16
Shanghai 16
Atlanta 15
London 15
Amsterdam 14
Brussels 14
Chicago 14
Johannesburg 14
Rio de Janeiro 14
Warsaw 14
Boston 13
Denver 13
Espoo 13
Foligno 13
Milan 13
San Paolo di Civitate 13
Tokyo 13
Baghdad 12
Falkenstein 12
Phoenix 12
Stockholm 12
Tashkent 12
Brasília 11
Chennai 11
San Francisco 11
Guangzhou 10
Izmir 10
Hefei 9
Philadelphia 9
Bologna 8
Bucharest 8
Da Nang 8
Redmond 8
Toronto 8
Florence 7
Lahore 7
Quito 7
San Diego 7
Seattle 7
Barnet 6
Belo Horizonte 6
Brno 6
Charlotte 6
Dearborn 6
Dhaka 6
Manchester 6
Medellín 6
Mexico City 6
Mumbai 6
Nairobi 6
Oklahoma City 6
Ottawa 6
Riyadh 6
San José 6
Vienna 6
Totale 5.718
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 168
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 161
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 152
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 152
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 151
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 140
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 139
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 134
"Designed" grafts for HLA-haploidentical stem cell transplantation. 131
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 131
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 130
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 130
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 127
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 126
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 126
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 126
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 125
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 125
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 124
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 123
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 120
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 120
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 120
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 118
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 115
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 112
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 109
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 109
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 107
Natural killer cell alloreactivity for leukemia therapy. 107
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 104
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 104
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 103
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 102
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 101
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 100
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 99
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 99
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 99
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 99
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 99
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 99
Cellular therapy: exploiting NK cell alloreactivity in transplantation 98
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 98
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 96
Natural killer cells: biology and application in stem-cell transplantation 96
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 95
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 95
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 95
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 95
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 94
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 93
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 93
New mechanism of lymphoma-induced bone marrow aplasia 93
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 92
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 92
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 92
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 91
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 90
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 90
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 89
Haploidentical transplantation and natural killer cell recognition of missing self. 88
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 87
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 87
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 87
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 86
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 85
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 81
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 80
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 79
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 77
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 77
Natural killer cells as a therapeutic tool in mismatched transplantation 77
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 76
Jack of all trades: thymosin α1 and its pleiotropy. 75
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 72
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 71
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 71
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 71
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 70
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 70
Next generation HLA-haploidentical HSCT 70
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 70
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 69
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 66
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 66
NK cells: a lesson from mismatched hematopoietic transplantation 65
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 63
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 62
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 56
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 54
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 54
null 46
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 40
null 36
null 27
EXTRAMEDULLARY INVOLVEMENT IN PATIENT-DERIVED XENOGRAFT MODELS OF ACUTE MYELOID LEUKEMIA (AML) WITH NUCLEOPHOSMIN (NPM-1) MUTATION 22
A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms 20
null 11
CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GvL while limiting GvHD after HSCT 8
Totale 9.315
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.995
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022595 0 0 0 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/20251.380 23 136 34 89 199 60 51 119 235 71 216 147
2025/20263.042 210 202 173 331 436 293 510 146 349 286 66 40
2026/2027512 74 103 179 156 0 0 0 0 0 0 0 0
Totale 9.315